Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosalt Regulatory News (SALT)

Share Price Information for Microsalt (SALT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £14.03m
SALT Live PriceLast checked at - London Stock Exchange

Intraday Microsalt Share Chart

FDA Nutrition information on packaged foods

16 Jan 2025 07:00

RNS Number : 5094T
MicroSalt PLC
16 January 2025
 

 

 

This is a Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance.

 

 

16 January 2025

 

MicroSalt plc

("MicroSalt®" or the "Company")

FDA Proposes Requiring At-a-Glance Nutrition Information on the Front of Packaged Foods

 

MicroSalt plc (AIM: SALT), a leading provider of full-flavour natural salt with approximately 50% less sodium, is pleased to announce the US FDA has just proposed requiring At-a-Glance Nutrition Information on the Front of Packaged Foods ("FOP") to indicate sodium levels, fat and added sugars.[1]

 

The proposed FOP nutrition label provides information on saturated fat, sodium and added sugars content in a simple format showing whether the food has "Low," "Med" or "High" levels of these nutrients.[2]

 

Image courtesy of the US FDA

 

The proposal comes after the FDA conducted an experimental study of nearly 10,000 U.S. adults in 2023 to identify which FOP schemes enabled participants to make quicker and more accurate assessments of the healthiness of a product.[3]

 

Rick Guiney, CEO of MicroSalt, commented: 

"The FDA proposed front of package guideline is a game changer for the packaged food and beverage industry in the United States. It will provide consumers readily visible information about a food's saturated fat, sodium and added sugars content-three nutrients directly linked to chronic diseases when consumed in excess. Additionally, the new FOP guidelines support Microsalt's® position as a leading food ingredient for US food manufacturers to use in their reformulation efforts to provide a healthier, consumer friendly product."

 

 

 

About MicroSalt plc

MicroSalt® is dedicated to innovating food technology solutions that enable people to live longer, healthier, and happier lives. Its patented low-sodium salt delivers natural salt with approximately 50% less sodium and may be used by both consumers and food manufacturers to decrease the amount of sodium in their food. SaltMe! chips are produced using MicroSalt®, a patented innovative salt technology which is 100% natural, non-GMO, gluten free, and Kosher certified, that does not contain any potassium chloride.

 

For more information, please visit www.microsaltinc.co, follow on X @microSaltPLC or contact:

 

MicroSalt plc

Via Flagstaff PR

Rick Guiney, CEO 

Flagstaff PR (Financial PR)  

+44 (0)20 7129 1474

Tim Thompson / Alison Allfrey / Anna Probert

microsalt@flagstaffcomms.com

 

 

Notes to Editors

 

MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.

 

MicroSalt is a major potential disruptor in the food market, thanks to its micron-sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.

 

Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70% of the typical person's sodium intake is hidden in processed foods.

 

Operational since 2018, MicroSalt owns a patent-protected technology which we believe helps create high barriers to entry within the reduced-sodium salt market.

 

The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.

 

ENDS

 


[1] https://www.fda.gov/news-events/press-announcements/fda-proposes-requiring-glance-nutrition-information-front-packaged-foods

[2] IBID

[3] https://thehill.com/policy/healthcare/5085725-new-fda-rule-could-require-nutrition-information-to-be-on-front-of-packaged-foods/

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFZGMMMKFGKZZ
12
Date   Source Headline
1st Jul 20267:01 amRNSResult of AGM
1st Jul 20267:00 amRNSGrant of Options, PDMR Dealing & TVR
5th Jun 20267:00 amRNSNotice of AGM
28th May 20267:07 amRNSFinal Results
28th Apr 20267:00 amRNS-RMicroSalt Launches MicroSalt Fibre
5th Mar 20267:00 amRNS-RNew UK customer
2nd Mar 20267:00 amRNS-RMicroSalt Reaches One Billion Servings Milestone
13th Feb 20267:00 amRNSGrant of options and PDMR dealings
27th Jan 20267:25 amRNSSigned Joint Development Agreement
12th Jan 20267:00 amRNSTrading Update
15th Dec 20252:17 pmRNSAdmission, Director Dealings and TVR
12th Dec 20252:30 pmRNSResult of Retail Offer
9th Dec 20254:35 pmRNSLaunch of Retail Offer
9th Dec 20252:40 pmRNSSubscription to raise £1.5 million
21st Nov 20253:38 pmRNSExercise of Stock Options and Total Voting Rights
14th Nov 20257:00 amRNSTrading Update
12th Nov 20257:00 amRNSNew Strategic Relationship with Daiya Foods
30th Sep 20257:00 amRNSUnaudited Half-yearly Report
1st Sep 20257:00 amRNSBoard changes
18th Aug 20257:00 amRNSH1 2025 Trading Update
11th Aug 20257:00 amRNSMissed related party transaction
6th Aug 20257:38 amRNSRelated Party Transaction
27th Jun 20253:48 pmRNSResult of AGM
6th Jun 202512:30 pmRNSHolding(s) in Company
2nd Jun 20257:01 amRNSNotice of Investor Presentation 9th June 2025
2nd Jun 20257:00 amRNSFinal Results Year Ended 31 December Notice of AGM
24th Apr 20257:00 amRNSQ1 2025 Business Update
24th Mar 20257:00 amRNS-RIFE London Innovation in Nutritious Foods
19th Mar 20257:00 amRNS-RFast Award 2025
25th Feb 20257:00 amRNS-RTechnology of the Year 2025 Award
14th Feb 20251:22 pmRNSNotification of Major Holdings
14th Feb 20251:06 pmRNSNotification of Major Holdings
7th Feb 20257:00 amRNSFurther Re Fundraising
5th Feb 20257:00 amRNSExercise of Stock Options and Total Voting Rights
3rd Feb 20257:00 amRNSOversubscribed Fundraising of £2.3Million
16th Jan 20257:00 amRNS-RFDA Nutrition information on packaged foods
6th Jan 20254:51 pmRNSResults of General Meeting
10th Dec 20247:00 amRNSShareholder Circular and Notice of General Meeting
30th Oct 20247:00 amRNSNew and Follow-on B2B Customer Orders
18th Oct 20247:00 amRNSResponse to Share Price Movement
27th Sep 20247:00 amRNSMaiden Interim Results
16th Sep 20247:00 amRNSMultiple Placements of Products and B2B Progress
2nd Aug 20243:02 pmRNSNotification of Major Holdings
30th Jul 20247:00 amRNSExercise of Warrants and Total Voting Rights
16th Jul 20247:00 amRNSExercise Warrants PDMR Dealing Total Voting Rights
11th Jul 20247:00 amRNSExercise of Warrants and Total Voting Rights
2nd Jul 20243:31 pmRNSExercise of Warrants and Total Voting Rights
21st Jun 20243:17 pmRNSResult of AGM
17th Jun 202411:22 amRNSExercise Warrants PDMR Dealing Total Voting Rights
11th Jun 20247:00 amRNSExercise Warrants Options and Total Voting Rights
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.